Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms.
about
Lipoic Acid Pharmacokinetics at Baseline and 1 year in Secondary Progressive MS.Enantioselective Pharmacokinetics of α-Lipoic Acid in Rats.The Protective Effects of Alpha-Lipoic Acid and Coenzyme Q10 Combination on Ovarian Ischemia-Reperfusion Injury: An Experimental StudySupplementation with Phycocyanobilin, Citrulline, Taurine, and Supranutritional Doses of Folic Acid and Biotin-Potential for Preventing or Slowing the Progression of Diabetic Complications.Lipoic Acid Stimulates cAMP Production in Healthy Control and Secondary Progressive MS Subjects.Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model.
P2860
Enantiomer-selective pharmacokinetics, oral bioavailability, and sex effects of various alpha-lipoic acid dosage forms.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Enantiomer-selective pharmacok ...... lpha-lipoic acid dosage forms.
@ast
Enantiomer-selective pharmacok ...... lpha-lipoic acid dosage forms.
@en
Enantiomer-selective pharmacok ...... lpha-lipoic acid dosage forms.
@nl
type
label
Enantiomer-selective pharmacok ...... lpha-lipoic acid dosage forms.
@ast
Enantiomer-selective pharmacok ...... lpha-lipoic acid dosage forms.
@en
Enantiomer-selective pharmacok ...... lpha-lipoic acid dosage forms.
@nl
prefLabel
Enantiomer-selective pharmacok ...... lpha-lipoic acid dosage forms.
@ast
Enantiomer-selective pharmacok ...... lpha-lipoic acid dosage forms.
@en
Enantiomer-selective pharmacok ...... lpha-lipoic acid dosage forms.
@nl
P2093
P2860
P356
P1476
Enantiomer-selective pharmacok ...... lpha-lipoic acid dosage forms.
@en
P2093
Dan Ziegler
Julius Mungo
Peter Jürgen Cnota
Robert Hermann
P2860
P304
P356
10.2147/CPAA.S71574
P407
P577
2014-11-28T00:00:00Z